High mobility group box 1 (HMGB1) is a key regulator of erastin-induced ferroptosis via the RAS-JNK/p38 pathway and is also expected to be a potential drug target in leukemia (Ye et al., 2019). This evidence concerns the gene HMGB1 and leukemia.